rac 1-Oleoyl-2-linoleoyl-3-chloropropanediol
- $460 - $1455
- Product name: rac 1-Oleoyl-2-linoleoyl-3-chloropropanediol
- CAS: 1336935-03-5
- MF: C39H69ClO4
- MW: 637.42
- EINECS:
- MDL Number:
- Synonyms:rac 1-Oleoyl-2-linoleoyl-3-chloropropanediol;[3-chloro-2-[(9Z,12Z)-octadeca-9,12-dienoyl]oxypropyl] (Z)-octadec-9-enoate;1-Oleoyl-2-linoleoyl-3-chloropropanediol;9,12-Octadecadienoic acid (9Z,12Z)-, 1-(chloromethyl)-2-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]ethyl ester
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- TRC
- Usbiological
Package
- 5MG
- 25mg
- 250mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberLIP0003825
- Product descriptionRAC-1-OLEOYL-2-LINOLEOYL-3-CHLOROPROPANEDIOL 95.00%
- Packaging5MG
- Price$501.4
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberO530500
- Product descriptionrac1-Oleoyl-2-linoleoyl-3-chloropropanediol
- Packaging250mg
- Price$1455
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number018755
- Product descriptionrac 1-Oleoyl-2-linoleoyl-3-chloropropanediol
- Packaging25mg
- Price$460
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | LIP0003825 | RAC-1-OLEOYL-2-LINOLEOYL-3-CHLOROPROPANEDIOL 95.00% | 5MG | $501.4 | 2021-12-16 | Buy |
TRC | O530500 | rac1-Oleoyl-2-linoleoyl-3-chloropropanediol | 250mg | $1455 | 2021-12-16 | Buy |
Usbiological | 018755 | rac 1-Oleoyl-2-linoleoyl-3-chloropropanediol | 25mg | $460 | 2021-12-16 | Buy |
Properties
storage temp. :Refrigerator
solubility :Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
form :Oil
color :Colourless
Stability :Light Sensitive
solubility :Chloroform (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
form :Oil
color :Colourless
Stability :Light Sensitive
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|